G. P. Tikhova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
G. P. Tikhova has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Efim Munevich Shifman
Pirogov Russian National Research Medical University
7 shared publications - Arina P. Spasova
Petrozavodsk State University, Petrozavodsk, Russia
4 shared publications - Olga Yu. Barisheva
Petrozavodsk State University
4 shared publications - Alexander V. Kulikov
Ural State Medical University
2 shared publications E Shifman
Kulakov Scientific Center of Obstetrics, Gynecology and Perinatology, Moscow, Russia
2 shared publications- Evgeny N. Degtyaryov
Mukhin City Clinical Hospital
2 shared publications
Latest Publications
- 4 June 2026
- Published by Media Sphere Publishing Group in Russian Journal of Anesthesiology and Reanimatology
- No. 3
Predictors of outcomes after intensive care for congenital malformations in early neonatal period
Predicting the outcomes of intensive care for congenital malformations (CM) in newborns is one of the most serious problems in neonatology. Objective. To identify predictors of intensive care outcomes in CM children requiring surgery in early neonatal period according to endocrine status. Material and methods. There were 34 newborns with CM and gestation period 39.23 (38—40) weeks. Diaphragmatic hernia (25%), esophageal atresia with tracheoesophageal fistula (20%), Ledd syndrome (10%) and omphalocele (15%) were the most common. Mean age of children was 2.5 (1—4) days. Results. A new prediction model for ventilation time includes serum cortisone and cholecalciferol after surgery, concentration of dehydroepiandrosterone a day after surgery and SpO2 immediately after surgery. Sensitivity was 0.832, specificity — 0.956, AUC — 0.958. To assess the probability of long-term ICU-stay (> 5 days) in patients with favorable outcomes, appropriate model involves concentration of 17-OH pregnenolone immediately after surgery, gradients of 17-OH pregnenolone and progesterone, as well as the ratio of 17-OH pregnenolone and aldosterone immediately after surgery and one day later (sensitivity — 0.842; specificity — 0.9; AUC — 0.942). The only independent predictor of adverse outcomes in CM newborns is lactate concentration. Its concentration was significantly higher in deceased children immediately after surgery (5.6 vs 2.2 mmol/L; p< 0.05) and a day later (6.1 vs 1.8 mmol/L; p< 0.05). The probability of unfavorable outcome is significantly higher in case of the ratio of 17-hydroxypregnenolone/corticosterone and 17-hydroxypregnenolone/cortisone equal to zero on the first day after surgery. Conclusion. Depletion of hormone precursors immediately after surgery and on the first day after surgery is a risk factor for unfavorable outcomes.
- 4 June 2026
- Published by Media Sphere Publishing Group in Russian Journal of Anesthesiology and Reanimatology
- No. 3
Predictors of outcomes after intensive care for congenital malformations in early neonatal period
Predicting the outcomes of intensive care for congenital malformations (CM) in newborns is one of the most serious problems in neonatology. Objective. To identify predictors of intensive care outcomes in CM children requiring surgery in early neonatal period according to endocrine status. Material and methods. There were 34 newborns with CM and gestation period 39.23 (38—40) weeks. Diaphragmatic hernia (25%), esophageal atresia with tracheoesophageal fistula (20%), Ledd syndrome (10%) and omphalocele (15%) were the most common. Mean age of children was 2.5 (1—4) days. Results. A new prediction model for ventilation time includes serum cortisone and cholecalciferol after surgery, concentration of dehydroepiandrosterone a day after surgery and SpO2 immediately after surgery. Sensitivity was 0.832, specificity — 0.956, AUC — 0.958. To assess the probability of long-term ICU-stay (> 5 days) in patients with favorable outcomes, appropriate model involves concentration of 17-OH pregnenolone immediately after surgery, gradients of 17-OH pregnenolone and progesterone, as well as the ratio of 17-OH pregnenolone and aldosterone immediately after surgery and one day later (sensitivity — 0.842; specificity — 0.9; AUC — 0.942). The only independent predictor of adverse outcomes in CM newborns is lactate concentration. Its concentration was significantly higher in deceased children immediately after surgery (5.6 vs 2.2 mmol/L; p< 0.05) and a day later (6.1 vs 1.8 mmol/L; p< 0.05). The probability of unfavorable outcome is significantly higher in case of the ratio of 17-hydroxypregnenolone/corticosterone and 17-hydroxypregnenolone/cortisone equal to zero on the first day after surgery. Conclusion. Depletion of hormone precursors immediately after surgery and on the first day after surgery is a risk factor for unfavorable outcomes.
- 18 January 2025
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 28 (4) , 82-90
Analysis of the effectiveness of anemia correction in CKD stage 5 on the basis of the "V.A. Baranov Republican Hospital" in Karelia Republic
BACKGROUND. Nephrogenic anemia is a serious problem in patients with chronic kidney disease, requiring a careful approach and adequate treatment. This condition manifests at the first stage and steadily progresses as GFR decreases. Therefore, timely correction of renal anemia with iron supplements and erythropoiesis stimulate agents (ESA) in CKD C5 is an integral component of therapy to reach target Hb values.THE AIM. This paper provides an analysis of the effectiveness of erythropoiesis-stimulating therapy among patients with end-stage CKD (C5d) receiving treatment with program hemodialysis on the basis of the Republican hospital named V.A. Baranov.PATIENTS AND METHODS. During the year 2022, 107 patients with end-stage CKD were observed. All of them had been receiving renal replacement therapy through a hemodialysis program (1284 patientmonths) and erythropoiesis-stimulating therapy with monthly monitoring of hemoglobin levels, following the clinical guidelines «Anemia in chronic kidney disease – 2020-2021-2022».RESULTS. The median hemoglobin level for 2022 was 107.8 g/L. The average annual increase was 8.9 g/l. Overall, the hemoglobin level in patients who did not receive EPO was 115.5 g/l. Patients receiving EPO who did not reach the target hemoglobin level (IR: 100-120 g/L) had a median hemoglobin of 92.5 g/L. To achieve the presented levels of anemia correction, the average weekly dose was 6,785 IU when calculated for the entire year 2022, including those patient months when EPO was not used.CONCLUSIONS. During treatment with EPO drugs, an increase in hemoglobin levels is observed, patients' quality of life improves, the risks of cardiovascular complications decrease, performance and physical endurance increase, the frequency and duration of hospitalizations decrease, and the need for blood transfusions decreases. The main challenges in solving the problem of refractory anemia involve individualizing treatment, considering drug response, and identifying additional factors.
- 18 January 2025
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 28 (4) , 82-90
Analysis of the effectiveness of anemia correction in CKD stage 5 on the basis of the "V.A. Baranov Republican Hospital" in Karelia Republic
BACKGROUND. Nephrogenic anemia is a serious problem in patients with chronic kidney disease, requiring a careful approach and adequate treatment. This condition manifests at the first stage and steadily progresses as GFR decreases. Therefore, timely correction of renal anemia with iron supplements and erythropoiesis stimulate agents (ESA) in CKD C5 is an integral component of therapy to reach target Hb values.THE AIM. This paper provides an analysis of the effectiveness of erythropoiesis-stimulating therapy among patients with end-stage CKD (C5d) receiving treatment with program hemodialysis on the basis of the Republican hospital named V.A. Baranov.PATIENTS AND METHODS. During the year 2022, 107 patients with end-stage CKD were observed. All of them had been receiving renal replacement therapy through a hemodialysis program (1284 patientmonths) and erythropoiesis-stimulating therapy with monthly monitoring of hemoglobin levels, following the clinical guidelines «Anemia in chronic kidney disease – 2020-2021-2022».RESULTS. The median hemoglobin level for 2022 was 107.8 g/L. The average annual increase was 8.9 g/l. Overall, the hemoglobin level in patients who did not receive EPO was 115.5 g/l. Patients receiving EPO who did not reach the target hemoglobin level (IR: 100-120 g/L) had a median hemoglobin of 92.5 g/L. To achieve the presented levels of anemia correction, the average weekly dose was 6,785 IU when calculated for the entire year 2022, including those patient months when EPO was not used.CONCLUSIONS. During treatment with EPO drugs, an increase in hemoglobin levels is observed, patients' quality of life improves, the risks of cardiovascular complications decrease, performance and physical endurance increase, the frequency and duration of hospitalizations decrease, and the need for blood transfusions decreases. The main challenges in solving the problem of refractory anemia involve individualizing treatment, considering drug response, and identifying additional factors.
- 21 August 2024
- Published by Media Sphere Publishing Group in Russian Journal of Anesthesiology and Reanimatology
- No. 4
Diagnosis of early neonatal infections in premature newborns
Objective. To evaluate significance of risk factors, clinical and laboratory indicators in diagnosis of early neonatal infections in premature neonates. Material and methods. A prospective single-center observational study included 385 newborns between 2021 and 2022. Mean gestation period was 35 (33—39) weeks, birth weight — 2500 (1850—3350) g. All children were divided into two groups depending on intraamniotic infection (IAI): group I — IAI, group II — no IAI. All children underwent clinical, laboratory and bacteriological examination within an hour after admission. Negative results of bacteriological examination were registered in 274 (71.4%) children. Among infected cases, Staphylococcus epidermidis (50%) and Klebsiella pneumoniae (14.5%) were the most common. Results. WBC count and neutrophil index were similar in both groups. Significant prognostic factors of early neonatal infection are low birth weight (35 mg/l upon admission to ICU. Anhydrous interval >9 hours increases the risk of IAI by 2 times. Conclusion. Analysis of risk factors depending on anhydrous interval and C-reactive protein allows identifying the newborns with high probability of early neonatal infection.
- 21 August 2024
- Published by Media Sphere Publishing Group in Russian Journal of Anesthesiology and Reanimatology
- No. 4
Diagnosis of early neonatal infections in premature newborns
Objective. To evaluate significance of risk factors, clinical and laboratory indicators in diagnosis of early neonatal infections in premature neonates. Material and methods. A prospective single-center observational study included 385 newborns between 2021 and 2022. Mean gestation period was 35 (33—39) weeks, birth weight — 2500 (1850—3350) g. All children were divided into two groups depending on intraamniotic infection (IAI): group I — IAI, group II — no IAI. All children underwent clinical, laboratory and bacteriological examination within an hour after admission. Negative results of bacteriological examination were registered in 274 (71.4%) children. Among infected cases, Staphylococcus epidermidis (50%) and Klebsiella pneumoniae (14.5%) were the most common. Results. WBC count and neutrophil index were similar in both groups. Significant prognostic factors of early neonatal infection are low birth weight (35 mg/l upon admission to ICU. Anhydrous interval >9 hours increases the risk of IAI by 2 times. Conclusion. Analysis of risk factors depending on anhydrous interval and C-reactive protein allows identifying the newborns with high probability of early neonatal infection.
- Open Access
- 20 June 2024
- Published by Kemerovo State Medical University in Fundamental and Clinical Medicine
- Vol. 9 (2) , 37-54
Outcomes of Placental Abruption Depending on Severity of Pre-Eclampsia: A Multicentre Cohort Observational Retrospective Study
Aim. Placental abruption is a severe complication of pregnancy, which is often accompanied by pre-eclampsia and early delivery. Here we aimed to study maternal and neonatal outcomes in patients with placental abruption depending on the severity of pre-eclampsia.Materials and Methods. The study included 509 patients with placental abruption and pre-eclampsia from 22 medical centers in 16 regions of the Russian Federation, which were divided into two groups: patients with placental abruption and severe pre-eclampsia (n = 369) and patients with placental abruption and moderate pre-eclampsia (n = 140).Results. Regardless of the severity of pre-eclampsia, average term of placental abruption was 34 weeks of pregnancy. Among the adverse maternal outcomes in patients with placental abruption and severe pre-eclampsia were coagulopathy (OR = 5.01; 95% CI = 1.17–21.46) and near miss proportion (OR = 2.95; 95% CI =1.22 –7.08) which were significantly more common as compared to a moderate pre-eclampsia. Neonatal outcomes were accompanied by a high perinatal mortality (12.8%) and neonatal morbidity due to a high prevalence of premature birth (65%), asphyxia (64%), and small for gestational age (40%). Groups with severe and moderate pre-eclampsia had no statistically significant differences in neonatal outcomes, excepting congenital malformations which were found less frequently (OR = 0.32; 95% CI 0.13–0.79) in severe pre-eclampsia.Conclusion. Severity of pre-eclampsia did not affect neonatal outcomes in women with placental abruption. Maternal outcomes were significantly worse in patients with severe pre-eclampsia in comparison with those with moderate pre-eclampsia.
- 20 June 2024
- Published by Kemerovo State Medical University in Fundamental and Clinical Medicine
- Vol. 9 (2) , 37-54
Open AccessOutcomes of Placental Abruption Depending on Severity of Pre-Eclampsia: A Multicentre Cohort Observational Retrospective Study
Aim. Placental abruption is a severe complication of pregnancy, which is often accompanied by pre-eclampsia and early delivery. Here we aimed to study maternal and neonatal outcomes in patients with placental abruption depending on the severity of pre-eclampsia.Materials and Methods. The study included 509 patients with placental abruption and pre-eclampsia from 22 medical centers in 16 regions of the Russian Federation, which were divided into two groups: patients with placental abruption and severe pre-eclampsia (n = 369) and patients with placental abruption and moderate pre-eclampsia (n = 140).Results. Regardless of the severity of pre-eclampsia, average term of placental abruption was 34 weeks of pregnancy. Among the adverse maternal outcomes in patients with placental abruption and severe pre-eclampsia were coagulopathy (OR = 5.01; 95% CI = 1.17–21.46) and near miss proportion (OR = 2.95; 95% CI =1.22 –7.08) which were significantly more common as compared to a moderate pre-eclampsia. Neonatal outcomes were accompanied by a high perinatal mortality (12.8%) and neonatal morbidity due to a high prevalence of premature birth (65%), asphyxia (64%), and small for gestational age (40%). Groups with severe and moderate pre-eclampsia had no statistically significant differences in neonatal outcomes, excepting congenital malformations which were found less frequently (OR = 0.32; 95% CI 0.13–0.79) in severe pre-eclampsia.Conclusion. Severity of pre-eclampsia did not affect neonatal outcomes in women with placental abruption. Maternal outcomes were significantly worse in patients with severe pre-eclampsia in comparison with those with moderate pre-eclampsia.
- Open Access
- 30 October 2023
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 4,p. 139-148
Sensory phenotypes of chronic pain in critically ill patients: a prospective observational study
INTRODUCTION: Determining sensory phenotypes that reflect underlying pain mechanisms may be relevant for critically ill patients with chronic pain. OBJECTIVE: To evaluate the intensity, localization and sensory phenotypes of chronic pain in critically ill patients. MATERIALS AND METHODS: The study included 99 critically ill patients. Inclusion criteria: age 18–75 years, length of stay in the ICU > 3 days, duration of mechanical ventilation > 48 hours, APACHE II score ≥ 7 points, obtaining informed consent. Localization, intensity, and qualitative characteristics of long-term (at least 6 months) pain associated with ICU stay were assessed using the Brief Pain Inventory and the PainDetect Questionnaire, and the severity of anxiety and depression on the HADS scale. Before discharge, all patients underwent thermal quantitative sensory testing (CST) with assessment of cold detection thresholds and warm detection thresholds, paradoxical thermal sensations, cold pain thresholds and heat pain thresholds, conditioned pain modulation. RESULTS: After 6 months chronic pain syndrome developed in 59 % of patients. Data were obtained on the intensity, localization, and severity of the neuropathic and dysfunctional components of pain. When assessing the thermal parameters of QST, a statistically significant difference in the distribution of values for the thresholds of sensitivity to cold and heat was obtained between the group of patients with chronic pain and the group without pain (p < 0.0001) Hierarchical cluster analysis revealed a statistically significant relationship between changes in static and dynamic parameters of thermal sensory testing, the formation of an “irritated” and “deafferent” sensory phenotype depending on the duration of mechanical ventilation, stay in the ICU and assessment on the SOFA scale. CONCLUSIONS: sensory phenotypes make it possible to identify patients with dysfunction of small diameter fibers, impaired endogenous pain control mechanisms, which will allow selecting an individual program to pain relief.
- 30 October 2023
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 4,p. 139-148
Open AccessSensory phenotypes of chronic pain in critically ill patients: a prospective observational study
INTRODUCTION: Determining sensory phenotypes that reflect underlying pain mechanisms may be relevant for critically ill patients with chronic pain. OBJECTIVE: To evaluate the intensity, localization and sensory phenotypes of chronic pain in critically ill patients. MATERIALS AND METHODS: The study included 99 critically ill patients. Inclusion criteria: age 18–75 years, length of stay in the ICU > 3 days, duration of mechanical ventilation > 48 hours, APACHE II score ≥ 7 points, obtaining informed consent. Localization, intensity, and qualitative characteristics of long-term (at least 6 months) pain associated with ICU stay were assessed using the Brief Pain Inventory and the PainDetect Questionnaire, and the severity of anxiety and depression on the HADS scale. Before discharge, all patients underwent thermal quantitative sensory testing (CST) with assessment of cold detection thresholds and warm detection thresholds, paradoxical thermal sensations, cold pain thresholds and heat pain thresholds, conditioned pain modulation. RESULTS: After 6 months chronic pain syndrome developed in 59 % of patients. Data were obtained on the intensity, localization, and severity of the neuropathic and dysfunctional components of pain. When assessing the thermal parameters of QST, a statistically significant difference in the distribution of values for the thresholds of sensitivity to cold and heat was obtained between the group of patients with chronic pain and the group without pain (p < 0.0001) Hierarchical cluster analysis revealed a statistically significant relationship between changes in static and dynamic parameters of thermal sensory testing, the formation of an “irritated” and “deafferent” sensory phenotype depending on the duration of mechanical ventilation, stay in the ICU and assessment on the SOFA scale. CONCLUSIONS: sensory phenotypes make it possible to identify patients with dysfunction of small diameter fibers, impaired endogenous pain control mechanisms, which will allow selecting an individual program to pain relief.
- 3 April 2023
- Published by Media Sphere Publishing Group in Russian Journal of Anesthesiology and Reanimatology
- No. 2
Hypertensive disorders in pregnancy as a risk factor of premature placental abruption: a systematic review and meta-analysis
Background. Hypertensive disorders in pregnancy are often cited as a significant risk for placental abruption. Objective. To study the effect of hypertensive disorders during pregnancy on the risk of premature placental abruption. Material and methods. Searching for literature data was performed in the PubMed, Google Scholar and Cochrane databases. We analyzed the effect of chronic hypertension and pregnancy-induced hypertension (including preeclampsia, gestational hypertension and eclampsia) on placental abruption. Results. The meta-analysis included 17 studies with a total of 30.184.624 patients. Hypertensive disorders in pregnancy increase the risk of premature placental abruption by almost 3 times (OR 2.79; 95% CI 2.37-3.27). In case of chronic hypertension only, the probability of placental abruption increases by about 2 times (OR 2.22; 95% CI 1.67-2.96). Conclusion. Hypertensive disorders in pregnancy are a significant risk of placental abruption.
- 3 April 2023
- Published by Media Sphere Publishing Group in Russian Journal of Anesthesiology and Reanimatology
- No. 2
Hypertensive disorders in pregnancy as a risk factor of premature placental abruption: a systematic review and meta-analysis
Background. Hypertensive disorders in pregnancy are often cited as a significant risk for placental abruption. Objective. To study the effect of hypertensive disorders during pregnancy on the risk of premature placental abruption. Material and methods. Searching for literature data was performed in the PubMed, Google Scholar and Cochrane databases. We analyzed the effect of chronic hypertension and pregnancy-induced hypertension (including preeclampsia, gestational hypertension and eclampsia) on placental abruption. Results. The meta-analysis included 17 studies with a total of 30.184.624 patients. Hypertensive disorders in pregnancy increase the risk of premature placental abruption by almost 3 times (OR 2.79; 95% CI 2.37-3.27). In case of chronic hypertension only, the probability of placental abruption increases by about 2 times (OR 2.22; 95% CI 1.67-2.96). Conclusion. Hypertensive disorders in pregnancy are a significant risk of placental abruption.
- 1 January 2021
- Published by Dynasty Publishing House in Voprosy Ginekologii, Akušerstva i Perinatologii
- Vol. 20 (3)
Preterm placental abruption. Epidemiology, risk factors. Systematic review
Preterm placental abruption is a multifactorial pregnancy complication, the etiology of which remains uncertain, and the risk of maternal morbidity and perinatal mortality is high. Over the past decade, the profile of obstetric patients has changed, as well as the approaches to medical care, and some risk factors for preterm placental abruption have also been revised. Objective. To summarize current knowledge about the epidemiology and causes of preterm placental abruption. Materials and methods. The search for publications was carried out in the electronic databases PubMed, Web of Science, SCOPUS, Google Scholar by four reviewers independently from January 1, 2017 to March 31, 2020. Clinical case reports, conference abstracts and studies with no comparison group were excluded. Results. Thirty-four studies involving 20,833,192 patients met the inclusion criteria, of whom 193,114 were diagnosed with preterm placental abruption, with an incidence of 0.93% (after excluding five studies with cross-sectional design, the overall incidence of preterm placental abruption decreased to 0.83%). According to the results obtained, among the undoubted risk factors for preterm placental abruption were smoking (odds ratio (OR) 1.72–13.0), anemia (OR 1.36–2.44), chronic kidney disease (OR 3.72– 5.51), the Negroid race (OR 1.47–3.59), uterine scar (OR 1.53–6.33) and uterine anomalies (OR 3.35–4.69). Contradictory information was received about the negative impact of the following factors: maternal age, assisted reproductive technologies, gynecological diseases, alcohol, various air pollutants and hot weather. Obesity was among the risk factors that did not affect preterm placental abruption (OR 0.81–0.74). Conclusion. The risk factors presented in the review were divided into groups. In the first two, timely correction of lifestyle and/or prescription of medicines can reduce the probability of preterm placental abruption. The third group is represented by risk factors, most of which are beyond regulation. However, to fully understand the etiology of preterm placental abruption, further qualitative studies with their more frequent systematization are required. Key words: pregnancy, ischemic placental disease, preterm placental abruption, risk factors, epidemiology
- 1 January 2021
- Published by Dynasty Publishing House in Voprosy Ginekologii, Akušerstva i Perinatologii
- Vol. 20 (3)
Preterm placental abruption. Epidemiology, risk factors. Systematic review
Preterm placental abruption is a multifactorial pregnancy complication, the etiology of which remains uncertain, and the risk of maternal morbidity and perinatal mortality is high. Over the past decade, the profile of obstetric patients has changed, as well as the approaches to medical care, and some risk factors for preterm placental abruption have also been revised. Objective. To summarize current knowledge about the epidemiology and causes of preterm placental abruption. Materials and methods. The search for publications was carried out in the electronic databases PubMed, Web of Science, SCOPUS, Google Scholar by four reviewers independently from January 1, 2017 to March 31, 2020. Clinical case reports, conference abstracts and studies with no comparison group were excluded. Results. Thirty-four studies involving 20,833,192 patients met the inclusion criteria, of whom 193,114 were diagnosed with preterm placental abruption, with an incidence of 0.93% (after excluding five studies with cross-sectional design, the overall incidence of preterm placental abruption decreased to 0.83%). According to the results obtained, among the undoubted risk factors for preterm placental abruption were smoking (odds ratio (OR) 1.72–13.0), anemia (OR 1.36–2.44), chronic kidney disease (OR 3.72– 5.51), the Negroid race (OR 1.47–3.59), uterine scar (OR 1.53–6.33) and uterine anomalies (OR 3.35–4.69). Contradictory information was received about the negative impact of the following factors: maternal age, assisted reproductive technologies, gynecological diseases, alcohol, various air pollutants and hot weather. Obesity was among the risk factors that did not affect preterm placental abruption (OR 0.81–0.74). Conclusion. The risk factors presented in the review were divided into groups. In the first two, timely correction of lifestyle and/or prescription of medicines can reduce the probability of preterm placental abruption. The third group is represented by risk factors, most of which are beyond regulation. However, to fully understand the etiology of preterm placental abruption, further qualitative studies with their more frequent systematization are required. Key words: pregnancy, ischemic placental disease, preterm placental abruption, risk factors, epidemiology
- Open Access
- 8 December 2020
- Published by ECO-Vector LLC in Regional Anesthesia and Acute Pain Management
- Vol. 14 (4) , 193-205
Factors and characteristics of chronic pain in survivors of critical conditions
This study aimed to determine the factors that affect the development of chronic pain in patients who recovered from a critical illness and to explore characteristics of pain. Material and methods. This study included a total of 112 patients with surgical pathology who stayed in the intensive care unit (ICU) and subsequently discharged from the hospital. Before discharge, patients were assessed using a short pain questionnaire, the PainDetect questionnaire to assess the neuropathic component of pain, and the HADS questionnaire to verify the presence of anxiety and depression. After 6 and 12 months, catanamnestic data were analyzed, and neuro-orthopedic examination and repeat testing were performed. The duration of ventilation and ICU and hospital stays were assessed as risk factors. The APACHE-II scale score and the maximum SOFA scale score were used as severity parameters of critical conditions. The maximum level of C-reactive protein (CRP) was recorded as a marker of inflammation. The Charlson comorbidity index was used to assess baseline comorbidity. Results. After 6 months, pain syndrome developed in 55.6% of the patients, and after 12 months, the average pain intensity was 4 points on the verbal rating scale in 59% of the patients. Neuropathic pain was diagnosed in 34% of the patients. The most frequent location of pain was the shoulder joint area, and both shoulders were affected by pain in 58.2% of the patients. In the period from 6 months to 1 year after discharge from the ICU, the risk factors for chronic pain were the duration of ventilator use, ICU stay, and CRP level. Age and gender did not affect the development of chronic pain in patients who recovered from critical illness. Conclusions. Chronic pain is a complication in more than half of the patients with critical illness. A third of patients with chronic pain experienced neuropathic pain, which requires a comprehensive approach to relieve pain.
- 8 December 2020
- Published by ECO-Vector LLC in Regional Anesthesia and Acute Pain Management
- Vol. 14 (4) , 193-205
Open AccessFactors and characteristics of chronic pain in survivors of critical conditions
This study aimed to determine the factors that affect the development of chronic pain in patients who recovered from a critical illness and to explore characteristics of pain. Material and methods. This study included a total of 112 patients with surgical pathology who stayed in the intensive care unit (ICU) and subsequently discharged from the hospital. Before discharge, patients were assessed using a short pain questionnaire, the PainDetect questionnaire to assess the neuropathic component of pain, and the HADS questionnaire to verify the presence of anxiety and depression. After 6 and 12 months, catanamnestic data were analyzed, and neuro-orthopedic examination and repeat testing were performed. The duration of ventilation and ICU and hospital stays were assessed as risk factors. The APACHE-II scale score and the maximum SOFA scale score were used as severity parameters of critical conditions. The maximum level of C-reactive protein (CRP) was recorded as a marker of inflammation. The Charlson comorbidity index was used to assess baseline comorbidity. Results. After 6 months, pain syndrome developed in 55.6% of the patients, and after 12 months, the average pain intensity was 4 points on the verbal rating scale in 59% of the patients. Neuropathic pain was diagnosed in 34% of the patients. The most frequent location of pain was the shoulder joint area, and both shoulders were affected by pain in 58.2% of the patients. In the period from 6 months to 1 year after discharge from the ICU, the risk factors for chronic pain were the duration of ventilator use, ICU stay, and CRP level. Age and gender did not affect the development of chronic pain in patients who recovered from critical illness. Conclusions. Chronic pain is a complication in more than half of the patients with critical illness. A third of patients with chronic pain experienced neuropathic pain, which requires a comprehensive approach to relieve pain.
- Open Access
- 22 November 2020
- Published by ECO-Vector LLC in Regional Anesthesia and Acute Pain Management
- Vol. 14 (2) , 72-85
Relationship between catechol-o-methyltransferase gene polymorphism and pain syndrome in breast cancer patients
The goal of the study was to explore the influence of single-nucleotide polymorphisms of the COMT gene on the formation and features of pain syndrome, the level of anxiety, and the need for narcotic analgesics in patients with breast cancer. Materials and methods. The intensity of pain and opioid consumption in the postoperative period were evaluated in 58 patients who met the inclusion criteria of the study and were operated for breast cancer. The frequency of chronic pain syndrome after mastectomy was studied in the same group of patients after a year by using short pain questionnaires, McGill Pain Questionnaire and PainDetect. The anxiety level was assessed by using the HADS questionnaire. Genotyping was performed for single-nucleotide polymorphisms, rs4680, rs740603, rs2097603 = rs2070577, rs4633, of the COMT gene localized in the 22q11.21 region in the studied group of patients. The relationship between the carrier of different genotypes and the intensity of acute and chronic pain, the severity of the pain rating index for sensory and affective characteristics, the presence of a neuropathic component of pain, and the severity of anxiety were studied in the entire sample. The use of narcotic analgesics was evaluated in the postoperative period (IU/day and IU/course) and for the relief of chronic pain. Results. It is shown that the intensity of postoperative pain and the severity of anxiety do not depend on the presence of a mutant allele for the studied polymorphisms of the COMT gene, while the postoperative consumption of opioids in patients with the rs4680 missense mutation in the exon of this gene is significantly less. The dependence of the intensity of chronic pain syndrome and the severity of anxiety on the presence of a mutant allele for the polymorphic locus rs4680 localized in the exon of the COMT gene was established. No significant relationship was observed between the mutant alleles and the use of opioids for chronic pain relief after mastectomy. Conclusion. Genotyping for the COMT gene polymorphisms can be useful for choosing the optimal tactics of pain management in patients with breast cancer.
- 22 November 2020
- Published by ECO-Vector LLC in Regional Anesthesia and Acute Pain Management
- Vol. 14 (2) , 72-85
Open AccessRelationship between catechol-o-methyltransferase gene polymorphism and pain syndrome in breast cancer patients
The goal of the study was to explore the influence of single-nucleotide polymorphisms of the COMT gene on the formation and features of pain syndrome, the level of anxiety, and the need for narcotic analgesics in patients with breast cancer. Materials and methods. The intensity of pain and opioid consumption in the postoperative period were evaluated in 58 patients who met the inclusion criteria of the study and were operated for breast cancer. The frequency of chronic pain syndrome after mastectomy was studied in the same group of patients after a year by using short pain questionnaires, McGill Pain Questionnaire and PainDetect. The anxiety level was assessed by using the HADS questionnaire. Genotyping was performed for single-nucleotide polymorphisms, rs4680, rs740603, rs2097603 = rs2070577, rs4633, of the COMT gene localized in the 22q11.21 region in the studied group of patients. The relationship between the carrier of different genotypes and the intensity of acute and chronic pain, the severity of the pain rating index for sensory and affective characteristics, the presence of a neuropathic component of pain, and the severity of anxiety were studied in the entire sample. The use of narcotic analgesics was evaluated in the postoperative period (IU/day and IU/course) and for the relief of chronic pain. Results. It is shown that the intensity of postoperative pain and the severity of anxiety do not depend on the presence of a mutant allele for the studied polymorphisms of the COMT gene, while the postoperative consumption of opioids in patients with the rs4680 missense mutation in the exon of this gene is significantly less. The dependence of the intensity of chronic pain syndrome and the severity of anxiety on the presence of a mutant allele for the polymorphic locus rs4680 localized in the exon of the COMT gene was established. No significant relationship was observed between the mutant alleles and the use of opioids for chronic pain relief after mastectomy. Conclusion. Genotyping for the COMT gene polymorphisms can be useful for choosing the optimal tactics of pain management in patients with breast cancer.
- Open Access
- 25 September 2018
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 3
The effect of oxytocin dose on the ST segment change, arterial hypotension and blood loss in women of different age groups during cesarean section
Oxytocin (OT) is a first-line drug in the prevention and treatment of postpartum hemorrhages. There are a number of studies showing that with prolonged infusion of OT, the concentration of the marker of myocardial damage of troponin and the depression of the ST segment on the ECG increase. As before, the question of hemodynamic effects and the effect on the myocardium of various doses of oxytocin, the concentrations of intravenous microfluidine administration in various categories of parturient women, remains unresolved. Objective. To conduct a comparative study of the effect of oxytocin dose on ST segment depression, during the operation, cesarean section under spinal anesthesia in somatically healthy primaparous young and optimal reproductive age. Materials and methods of research. A prospective, randomized study of ST-segment depression after administration of oxytocin was performed in 44 primaparous patients aged 15 to 25 years. Operative delivery was performed routinely under spinal anesthesia using a standard procedure. The conclusion about ST segment depression was made when the segment was located below the isoelectric 0.5 mm. All patients were randomized into 2 groups according to the dose of OT recommended by different clinical recommendations 5 and 10 units. Results. In our study, the risk of developing acute depression of the ST segment directly depended on the dose of injected uterotonics. Thus, in the group of patients who received RT at a dose of 10 U, the risk of developing depression of the ST segment was 8.6 times higher than in the group where the dose of OT was 5 units. Among young primaparas, the risk of developing depression of the ST segment is 9 times higher with the administration of OT in a dose of 10 units. Conclusion. Depression of the ST segment (more than 0.5 mm) directly depends on the dose of oxytocin administered during the operation by cesarean section.
- 25 September 2018
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 3
Open AccessThe effect of oxytocin dose on the ST segment change, arterial hypotension and blood loss in women of different age groups during cesarean section
Oxytocin (OT) is a first-line drug in the prevention and treatment of postpartum hemorrhages. There are a number of studies showing that with prolonged infusion of OT, the concentration of the marker of myocardial damage of troponin and the depression of the ST segment on the ECG increase. As before, the question of hemodynamic effects and the effect on the myocardium of various doses of oxytocin, the concentrations of intravenous microfluidine administration in various categories of parturient women, remains unresolved. Objective. To conduct a comparative study of the effect of oxytocin dose on ST segment depression, during the operation, cesarean section under spinal anesthesia in somatically healthy primaparous young and optimal reproductive age. Materials and methods of research. A prospective, randomized study of ST-segment depression after administration of oxytocin was performed in 44 primaparous patients aged 15 to 25 years. Operative delivery was performed routinely under spinal anesthesia using a standard procedure. The conclusion about ST segment depression was made when the segment was located below the isoelectric 0.5 mm. All patients were randomized into 2 groups according to the dose of OT recommended by different clinical recommendations 5 and 10 units. Results. In our study, the risk of developing acute depression of the ST segment directly depended on the dose of injected uterotonics. Thus, in the group of patients who received RT at a dose of 10 U, the risk of developing depression of the ST segment was 8.6 times higher than in the group where the dose of OT was 5 units. Among young primaparas, the risk of developing depression of the ST segment is 9 times higher with the administration of OT in a dose of 10 units. Conclusion. Depression of the ST segment (more than 0.5 mm) directly depends on the dose of oxytocin administered during the operation by cesarean section.